logo
SamsungBioepisandATLATLSignMemorandumofUnderstanding(MoU)toAccelerateEarly-StageBiotechInnovationinAsia-Pacific
===2026/4/29 13:08:02===
in Beijing, Shanghai, Shenzhen, Singapore, Hong Kong, and other strategic locations.

ATLATL provides clients with comprehensive research and development services covering various stages, including in vitro drug screening, in vivo disease model establishment, and efficacy evaluation. ATLATL also supports key applications such as large molecule, small molecule, nucleic acid drugs, gene and cell therapy, drug delivery, as well as cutting-edge fields like multi-omics, gene editing, organoids, and organ-on-a-chip. Additionally, ATLATL provides an outstanding experimental environment and professional operational management for scientific researchers.

Through in-depth cooperation with leading global enterprises and research institutions, ATLATL continuously integrates research and development resources and promotes the sharing of new technologies. With advanced systematic research and development models, ATLATL accelerates the engineering process of life sciences, enab
=*=*=*=*=*=
当前为第4/5页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页